Healthcare provider profile · identity verified

Cailin Mcdeed, D.O.

Family Practice · NORTHBRIDGE, MA · NPI 1508228545

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	361	108
Lisinopril	Lisinopril	184	54
Omeprazole	Omeprazole	142	37
Levothyroxine Sodium	Levothyroxine Sodium	135	39
Losartan Potassium	Losartan Potassium	129	38
Gabapentin	Gabapentin	124	38
Amlodipine Besylate	Amlodipine Besylate	104	40
Hydrochlorothiazide	Hydrochlorothiazide	101	29
Rosuvastatin Calcium	Rosuvastatin Calcium	91	33
Simvastatin	Simvastatin	77	24
Metformin Hcl	Metformin Hcl	73	27
Metoprolol Succinate	Metoprolol Succinate	69	20
Albuterol Sulfate Hfa	Albuterol Sulfate	68	22
Furosemide	Furosemide	61	23
Sertraline Hcl	Sertraline Hcl	60	19
Lorazepam	Lorazepam	54	22
Escitalopram Oxalate	Escitalopram Oxalate	50	11
Fluticasone Propionate	Fluticasone Propionate	50	29
Pantoprazole Sodium	Pantoprazole Sodium	46	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Atenolol	Atenolol	43	13
Jardiance	Empagliflozin	41	12
Alendronate Sodium	Alendronate Sodium	39	suppressed
Alprazolam	Alprazolam	37	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	13
Trazodone Hcl	Trazodone Hcl	37	suppressed
Famotidine	Famotidine	35	14
Pravastatin Sodium	Pravastatin Sodium	35	12
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Metformin Hcl Er	Metformin Hcl	34	11
Metoprolol Tartrate	Metoprolol Tartrate	32	12
Doxycycline Monohydrate	Doxycycline Monohydrate	31	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Meloxicam	Meloxicam	31	suppressed
Potassium Chloride	Potassium Chloride	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	17
Ozempic	Semaglutide	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Prednisone	Prednisone	24	21
Valsartan	Valsartan	24	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	11
Allopurinol	Allopurinol	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Mounjaro	Tirzepatide	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Misoprostol	Misoprostol	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Belbuca	Buprenorphine Hcl	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error